{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:15:49Z","timestamp":1786994149000,"version":"build-2736575974"},"reference-count":95,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.metabol.2013.04.014","type":"journal-article","created":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T00:49:22Z","timestamp":1369356562000},"page":"1199-1205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Adipokines in the HIV\/HAART-associated lipodystrophy syndrome"],"prefix":"10.1016","volume":"62","author":[{"given":"Jason","family":"Paruthi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.metabol.2013.04.014_bb0005","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/jmv.20599","article-title":"Global epidemiology of HIV","volume":"78","author":"McCutchan","year":"2006","journal-title":"J Med Virol"},{"issue":"5 Pt 2","key":"10.1016\/j.metabol.2013.04.014_bb0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.7326\/0003-4819-137-5_Part_2-200209031-00001","article-title":"Guidelines for using antiretroviral agents among HIV-infected adults and adolescents","volume":"137","author":"Dybul","year":"2002","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.metabol.2013.04.014_bb0015","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.metabol.2012.03.003","article-title":"Changes of metabolic and inflammatory markers in HIV infection: glucose, lipids, serum hs-CRP and myeloperoxidase","volume":"61","author":"Borato","year":"2012","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.metabol.2013.04.014_bb0020","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/jc.2002-021704","article-title":"Clinical review 159: human immunodeficiency virus\/highly active antiretroviral therapy-associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies","volume":"88","author":"Leow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.metabol.2013.04.014_bb0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.metabol.2013.04.014_bb0030","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.metabol.2010.08.007","article-title":"Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood","volume":"60","author":"Dimock","year":"2011","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.metabol.2013.04.014_bb0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/QAI.0b013e3181a9992c","article-title":"Association of C-reactive protein and HIV infection with acute myocardial infarction","volume":"51","author":"Triant","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"10.1016\/j.metabol.2013.04.014_bb0040","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/QAI.0b013e3181f4b752","article-title":"Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system","volume":"55","author":"Triant","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.metabol.2013.04.014_bb0045","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (d:A:D) study","volume":"201","author":"Worm","year":"2010","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.metabol.2013.04.014_bb0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrendo.2010.199","article-title":"Lipodystrophy: pathophysiology and advances in treatment","volume":"7","author":"Fiorenza","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.metabol.2013.04.014_bb0055","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/QAI.0b013e3181aa1308","article-title":"The effect of individual antiretroviral drugs on body composition in HIV-infected persons initiating highly active antiretroviral therapy","volume":"51","author":"Shlay","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.metabol.2013.04.014_bb0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00042560-200201010-00004","article-title":"Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy","volume":"29","author":"Estrada","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.metabol.2013.04.014_bb0065","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/367859","article-title":"Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin","volume":"36","author":"Nagy","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.metabol.2013.04.014_bb0070","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1086\/339866","article-title":"Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy","volume":"34","author":"Sav\u00e8s","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.metabol.2013.04.014_bb0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jocd.2010.08.002","article-title":"The pilot study of DXA assessment in Chinese HIV-infected men with clinical lipodystrophy","volume":"14","author":"Yao","year":"2011","journal-title":"J Clin Densitom"},{"issue":"9","key":"10.1016\/j.metabol.2013.04.014_bb0080","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1053\/meta.2002.34704","article-title":"Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy","volume":"51","author":"Hadigan","year":"2002","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.metabol.2013.04.014_bb0085","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.metabol.2008.12.005","article-title":"Decreased respiratory quotient in relation to resting energy expenditure in HIV-infected and noninfected subjects","volume":"58","author":"Fitch","year":"2009","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.metabol.2013.04.014_bb0090","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbalip.2009.09.018","article-title":"Drug-induced lipotoxicity: lipodystrophy associated with HIV-1 infection and antiretroviral treatment","volume":"1801","author":"Villarroya","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"10.1016\/j.metabol.2013.04.014_bb0095","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.metabol.2007.02.007","article-title":"Impaired proinsulin secretion before and during oral glucose stimulation in HIV-infected patients who display fat redistribution","volume":"56","author":"Haugaard","year":"2007","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.metabol.2013.04.014_bb0100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/QAI.0b013e3181c190f4","article-title":"Insulin sensitivity in multiple pathways is differently affected during zidovudine\/lamivudine-containing compared with NRTI-sparing combination antiretroviral therapy","volume":"53","author":"van Vonderen","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"10.1016\/j.metabol.2013.04.014_bb0105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.metabol.2004.08.022","article-title":"Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapy","volume":"54","author":"Chaparro","year":"2005","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.metabol.2013.04.014_bb0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00002030-200201040-00003","article-title":"Effects of antiretroviral drug combinations on the differentiation of adipocytes","volume":"16","author":"Roche","year":"2002","journal-title":"AIDS"},{"issue":"3\u20134","key":"10.1016\/j.metabol.2013.04.014_bb0115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/em.20245","article-title":"Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long-term to zidovudine","volume":"48","author":"Divi","year":"2007","journal-title":"Environ Mol Mutagen"},{"issue":"11\u201312","key":"10.1016\/j.metabol.2013.04.014_bb0120","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3109\/00365540903186181","article-title":"Long term adverse effects related to nucleoside reverse transcriptase inhibitors: clinical impact of mitochondrial toxicity","volume":"41","author":"Maagaard","year":"2009","journal-title":"Scand J Infect Dis"},{"issue":"9","key":"10.1016\/j.metabol.2013.04.014_bb0125","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/QAD.0b013e32832b4377","article-title":"Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment","volume":"23","author":"Haubrich","year":"2009","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.metabol.2013.04.014_bb0130","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/me.2007-0124","article-title":"Human immunodeficiency virus (HIV)-1 viral protein r suppresses transcriptional activity of peroxisome proliferator-activated receptor gamma and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy","volume":"22","author":"Shrivastav","year":"2008","journal-title":"Mol Endocrinol"},{"issue":"1","key":"10.1016\/j.metabol.2013.04.014_bb0135","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.metabol.2005.07.012","article-title":"Hiv infection and high-density lipoprotein: the effect of the disease vs the effect of treatment","volume":"55","author":"Rose","year":"2006","journal-title":"Metabolism"},{"issue":"11","key":"10.1016\/j.metabol.2013.04.014_bb0140","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.metabol.2009.04.021","article-title":"Serum retinol-binding protein 4 correlates with obesity, insulin resistance, and dyslipidemia in HIV-infected subjects receiving highly active antiretroviral therapy","volume":"58","author":"Han","year":"2009","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.metabol.2013.04.014_bb0145","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.metabol.2009.04.011","article-title":"Obesity and lymphocyte subsets in virologically suppressed HIV-infected patients","volume":"58","author":"Adeyemi","year":"2009","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.metabol.2013.04.014_bb0150","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.metabol.2009.02.026","article-title":"Metabolic disorders induced by highly active antiretroviral therapy and their relationship with vascular remodeling of the brachial artery in a population of HIV-infected patients","volume":"58","author":"Rossi","year":"2009","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.metabol.2013.04.014_bb0155","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.metabol.2005.08.018","article-title":"Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy","volume":"55","author":"Haugaard","year":"2006","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.metabol.2013.04.014_bb0160","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.metabol.2009.02.012","article-title":"Adherence to Mediterranean diet is favorably associated with metabolic parameters in HIV-positive patients with the highly active antiretroviral therapy-induced metabolic syndrome and lipodystrophy","volume":"58","author":"Tsiodras","year":"2009","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.metabol.2013.04.014_bb0165","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1210\/jc.2002-020709","article-title":"Sustained benefits of metformin therapy on markers of cardiovascular risk in human immunodeficiency virus-infected patients with fat redistribution and insulin resistance","volume":"87","author":"Hadigan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"41","key":"10.1016\/j.metabol.2013.04.014_bb0170","doi-asserted-by":"crossref","first-page":"29946","DOI":"10.1074\/jbc.M702490200","article-title":"Adipose tissue integrity as a prerequisite for systemic energy balance: a critical role for peroxisome proliferator-activated receptor gamma","volume":"282","author":"Anghel","year":"2007","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.metabol.2013.04.014_bb0175","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1468-1293.2007.00488.x","article-title":"A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy","volume":"8","author":"Kohli","year":"2007","journal-title":"HIV Med"},{"issue":"9407","key":"10.1016\/j.metabol.2013.04.014_bb0180","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(04)15489-5","article-title":"No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial","volume":"363","author":"Carr","year":"2004","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.metabol.2013.04.014_bb0185","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1463-1326.2008.00978.x","article-title":"Prolonged thiazolidinedione therapy does not reverse fat loss in patients with familial partial lipodystrophy, Dunnigan variety","volume":"10","author":"Simha","year":"2008","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"10.1016\/j.metabol.2013.04.014_bb0190","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.metabol.2010.07.023","article-title":"Effects of rosiglitazone on abnormal lipid kinetics in HIV-associated dyslipidemic lipodystrophy: a stable isotope study","volume":"60","author":"Sekhar","year":"2011","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.metabol.2013.04.014_bb0195","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2337\/diabetes.50.6.1378","article-title":"The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance","volume":"50","author":"Caron","year":"2001","journal-title":"Diabetes"},{"issue":"Pt 18","key":"10.1016\/j.metabol.2013.04.014_bb0200","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1242\/jcs.00044","article-title":"Reduced IRS-2 and GLUT4 expression in PPARgamma2-induced adipocytes derived from C\/EBPbeta and C\/EBPdelta-deficient mouse embryonic fibroblasts","volume":"115","author":"Yamamoto","year":"2002","journal-title":"J Cell Sci"},{"issue":"1\u20133","key":"10.1016\/j.metabol.2013.04.014_bb0205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(01)01053-6","article-title":"Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARgamma mRNA expression in 3t3-l1 adipocytes","volume":"422","author":"Takamura","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.metabol.2013.04.014_bb0210","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/427697","article-title":"Improvement in highly active antiretroviral therapy-induced metabolic syndrome by treatment with pioglitazone but not with fenofibrate: a 2 \u00d7 2 factorial, randomized, double-blinded, placebo-controlled trial","volume":"40","author":"Gavrila","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.metabol.2013.04.014_bb0215","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/jc.2002-020795","article-title":"Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy","volume":"88","author":"Addy","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.metabol.2013.04.014_bb0220","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/QAD.0b013e3280adc91e","article-title":"The role of adipokines in relation to HIV lipodystrophy","volume":"21","author":"Sweeney","year":"2007","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.metabol.2013.04.014_bb0225","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.metabol.2011.04.008","article-title":"Effects of leptin and adiponectin on pancreatic beta-cell function","volume":"60","author":"Lee","year":"2011","journal-title":"Metabolism"},{"issue":"6941","key":"10.1016\/j.metabol.2013.04.014_bb0230","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.metabol.2013.04.014_bb0235","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1073\/pnas.98.4.2005","article-title":"Proteolytic cleavage product of 30-kda adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice","volume":"98","author":"Fruebis","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.metabol.2013.04.014_bb0240","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.metabol.2013.04.014_bb0245","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","article-title":"Serum adiponectin and leptin levels in patients with lipodystrophies","volume":"87","author":"Haque","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.metabol.2013.04.014_bb0250","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1210\/jc.2002-021600","article-title":"Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices","volume":"88","author":"Tong","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.metabol.2013.04.014_bb0255","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/00002030-200307040-00011","article-title":"Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy","volume":"17","author":"Vigouroux","year":"2003","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.metabol.2013.04.014_bb0260","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.metabol.2011.03.009","article-title":"Plasma adiponectin\u2014an independent indicator of liver fat accumulation","volume":"60","author":"Pisto","year":"2011","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.metabol.2013.04.014_bb0265","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/10284150400009998","article-title":"Adiponectin: novelties in metabolism and hormonal regulation","volume":"7","author":"Duntas","year":"2004","journal-title":"Nutr Neurosci"},{"issue":"3","key":"10.1016\/j.metabol.2013.04.014_bb0270","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.yfrne.2010.06.002","article-title":"Leptin in human physiology and therapeutics","volume":"31","author":"Dardeno","year":"2010","journal-title":"Front Neuroendocrinol"},{"issue":"8","key":"10.1016\/j.metabol.2013.04.014_bb0275","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-130-8-199904200-00014","article-title":"The role of leptin in human obesity and disease: a review of current evidence","volume":"130","author":"Mantzoros","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2013.04.014_bb0280","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1210\/rp.59.1.305","article-title":"Leptin signaling in the central nervous system and the periphery","volume":"59","author":"Bjorbaek","year":"2004","journal-title":"Recent Prog Horm Res"},{"issue":"5","key":"10.1016\/j.metabol.2013.04.014_bb0285","first-page":"1407","article-title":"Clinical review 94: what's in a name? In search of leptin's physiologic role","volume":"83","author":"Flier","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"6704","key":"10.1016\/j.metabol.2013.04.014_bb0290","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"issue":"6748","key":"10.1016\/j.metabol.2013.04.014_bb0295","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","article-title":"Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy","volume":"401","author":"Shimomura","year":"1999","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.metabol.2013.04.014_bb0300","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.2337\/diabetes.50.6.1440","article-title":"Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes","volume":"50","author":"Ebihara","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2013.04.014_bb0305","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1749-6632.2000.tb06228.x","article-title":"Role of leptin in reproduction","volume":"900","author":"Mantzoros","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"10.1016\/j.metabol.2013.04.014_bb0310","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.metabol.2010.09.009","article-title":"Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: The Cyprus metabolism prospective cohort study","volume":"60","author":"Hamnvik","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2013.04.014_bb0315","doi-asserted-by":"crossref","unstructured":"Kelesidis T, Kelesidis I, Chou S, et al. Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 152(2): 93\u20139100.","DOI":"10.7326\/0003-4819-152-2-201001190-00008"},{"issue":"12","key":"10.1016\/j.metabol.2013.04.014_bb0320","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1074\/jbc.275.12.8456","article-title":"Mechanism of insulin resistance in A-ZIP\/F-1 fatless mice","volume":"275","author":"Kim","year":"2000","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.metabol.2013.04.014_bb0325","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.metabol.2010.03.016","article-title":"Leptin increases skeletal muscle lipoprotein lipase and postprandial lipid metabolism in mice","volume":"60","author":"Donahoo","year":"2011","journal-title":"Metabolism"},{"issue":"22","key":"10.1016\/j.metabol.2013.04.014_bb0330","doi-asserted-by":"crossref","first-page":"8481","DOI":"10.1073\/pnas.0505429103","article-title":"Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans","volume":"103","author":"Chan","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1016\/j.metabol.2013.04.014_bb0335","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.metabol.2011.05.016","article-title":"Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women","volume":"60","author":"Sienkiewicz","year":"2011","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.metabol.2013.04.014_bb0340","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.metabol.2011.05.020","article-title":"Leptin and the skeleton\u2014where is the fat?","volume":"60","author":"Gordon","year":"2011","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.metabol.2013.04.014_bb0345","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy","volume":"109","author":"Petersen","year":"2002","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.metabol.2013.04.014_bb0350","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2337\/diabetes.54.7.1994","article-title":"Long-term efficacy of leptin replacement in patients with generalized lipodystrophy","volume":"54","author":"Javor","year":"2005","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.metabol.2013.04.014_bb0355","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.metabol.2013.04.014_bb0360","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1210\/jc.2005-1545","article-title":"Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy","volume":"91","author":"Lee","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.metabol.2013.04.014_bb0365","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1210\/jc.2008-1588","article-title":"The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia","volume":"94","author":"Mulligan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.metabol.2013.04.014_bb0370","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.284.4.472","article-title":"Metformin in the treatment of HIV lipodystrophy syndrome: a randomized controlled trial","volume":"284","author":"Hadigan","year":"2000","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.metabol.2013.04.014_bb0375","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-140-10-200405180-00008","article-title":"Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial","volume":"140","author":"Hadigan","year":"2004","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.metabol.2013.04.014_bb0380","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.300.5.509","article-title":"Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial","volume":"300","author":"Lo","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.metabol.2013.04.014_bb0385","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00125-009-1502-9","article-title":"Efficacy of leptin therapy in the different forms of human lipodystrophy","volume":"53","author":"Chong","year":"2010","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.metabol.2013.04.014_bb0390","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.metabol.2012.03.013","article-title":"Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome","volume":"61","author":"Sekhar","year":"2012","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.metabol.2013.04.014_bb0395","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1210\/jc.2003-032140","article-title":"Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy","volume":"89","author":"Javor","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.metabol.2013.04.014_bb0400","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00125-009-1545-y","article-title":"Leptin therapy in lipodystrophy","volume":"53","author":"Savage","year":"2010","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.metabol.2013.04.014_bb0405","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4158\/EP09155.RA","article-title":"Rationale for leptin-replacement therapy for severe lipodystrophy","volume":"16","author":"Oral","year":"2010","journal-title":"Endocr Pract"},{"key":"10.1016\/j.metabol.2013.04.014_bb0410","first-page":"1","article-title":"W(h)ither metreleptin for lipodystrophy and the metabolic syndrome?","author":"Mantzoros","year":"2010","journal-title":"Endocr Pract"},{"issue":"7","key":"10.1016\/j.metabol.2013.04.014_bb0415","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.metabol.2010.10.002","article-title":"Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus-infected lipoatrophic men treated with pioglitazone: a pilot study","volume":"60","author":"Magkos","year":"2011","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.metabol.2013.04.014_bb0420","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/EJE-08-0597","article-title":"R-methuleptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating igf and igf-binding protein levels: observational and interventional studies in humans","volume":"160","author":"Brennan","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.metabol.2013.04.014_bb0425","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1210\/jc.2009-2502","article-title":"Effects of insulin-like growth factor (IGF)-I\/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance","volume":"95","author":"Rao","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"10.1016\/j.metabol.2013.04.014_bb0430","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/00002030-199910220-00013","article-title":"Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV","volume":"13","author":"Wanke","year":"1999","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.metabol.2013.04.014_bb0435","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/QAI.0b013e31804a7f68","article-title":"Recombinant human growth hormone to treat HIV-associated adipose redistribution syndrome: 12week induction and 24-week maintenance therapy","volume":"45","author":"Grunfeld","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.metabol.2013.04.014_bb0440","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1468-1293.2006.00399.x","article-title":"A randomized, open-label study to compare the effects of two different doses of recombinant human growth hormone on fat reduction and fasting metabolic parameters in HIV-1-infected patients with lipodystrophy","volume":"7","author":"Bickel","year":"2006","journal-title":"HIV Med"},{"issue":"10","key":"10.1016\/j.metabol.2013.04.014_bb0445","first-page":"3408","article-title":"Leptin concentrations in relation to body mass index and the tumor necrosis factor-alpha system in humans","volume":"82","author":"Mantzoros","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.metabol.2013.04.014_bb0450","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.metabol.2012.04.013","article-title":"Leptin in congenital or HIV-associated lipodystrophy and metabolic syndrome: a need for more mechanistic studies and large, randomized, placebo-controlled trials","volume":"61","author":"Foo","year":"2012","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.metabol.2013.04.014_bb0455","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.metabol.2010.09.011","article-title":"Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment","volume":"60","author":"Magkos","year":"2011","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.metabol.2013.04.014_bb0460","doi-asserted-by":"crossref","first-page":"E567","DOI":"10.1152\/ajpendo.00315.2011","article-title":"Leptin in human physiology and pathophysiology","volume":"301","author":"Mantzoros","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.metabol.2013.04.014_bb0465","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3844\/ajidsp.2006.141.152","article-title":"Leptin and adiponectin in the HIV associated metabolic syndrome: physiologic and therapeutic implications","volume":"2","author":"Tsiodras","year":"2006","journal-title":"Am J Infect Dis"},{"issue":"11","key":"10.1016\/j.metabol.2013.04.014_bb0470","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.metabol.2011.03.015","article-title":"Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug\u2013drug interaction in HIV patients","volume":"60","author":"Daali","year":"2011","journal-title":"Metabolism"},{"issue":"11","key":"10.1016\/j.metabol.2013.04.014_bb0475","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.metabol.2011.05.022","article-title":"Drug-drug interactions in HIV medicine: a not so simple and straightforward road to the future","volume":"60","author":"Tsiodras","year":"2011","journal-title":"Metabolism"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049513001315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049513001315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:01:12Z","timestamp":1758427272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049513001315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":95,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0026049513001315"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2013.04.014","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adipokines in the HIV\/HAART-associated lipodystrophy syndrome","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2013.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}